Project Grant R21NS145093
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The University of Pennsylvania a $446,875 Project Grant effective June 1, 2025, through May 31, 2027, under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853). The research project focuses on generating and characterizing a novel NTRK3-FLPO knockin mouse line to enable genetic interrogation of Aβ nociceptors—a previously inaccessible population of...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded the University of Pennsylvania a Project Grant totaling $667,349 (awarded August 1, 2025, with completion targeted for June 30, 2030) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. This research grant supports a neuroscience investigation into state-dependent control of nociception (pain sensation) in opioid circuits,...
- Federal Project Grant Award Summary The University of Pennsylvania received a $243,750 Project Grant award dated February 11, 2026, from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award supports research through December 31, 2027, to advance understanding of sleep and wake regulation mechanisms in the brain. The research will deliver single-nucleus gene...
- Federal Grant Award Summary The University of Pittsburgh received a $1.15 million Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded on March 15, 2025, with a completion date of January 31, 2030. The grant funds research to investigate the neuronal circuitry and central sensitization mechanisms underlying mechanical allodynia—a debilitating...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded $407,113 to the University of California, Irvine under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program on August 15, 2025, for an R21 exploratory research project extending through July 31, 2027. This project grant supports the development of novel KV7 channel modulators designed to mitigate chronic pain by preventing M-current suppression...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded $372,880 to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. on August 1, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. This project grant supports basic research investigating astrocyte calcium signaling mechanisms in chronic pain, with a performance period extending through May 31,...
- Federal Project Grant Award Summary The University of Pittsburgh received a $239,052 Project Grant awarded on June 12, 2025, from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The research project, "Targeting Spinal Orexins to Treat Chronic Pain," will be conducted through February 29, 2028, and seeks to advance understanding of how orexinergic neurons...
- Federal Project Grant Award Summary The University of Pittsburgh received a $620,504 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective February 11, 2026, with completion by November 30, 2030. This research project investigates how the brain resolves competing survival needs by examining neural circuits in the lateral parabrachial nucleus...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke awarded $226,530 to The Regents of the University of California, San Francisco under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) for a five-year project period commencing August 1, 2025, and concluding July 31, 2030. This career development award supports a clinician-investigator's independent research program focused on understanding how...
- Grant Award Summary The University of Pennsylvania received a $137,894 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, with an award date of May 9, 2025 and completion date of December 31, 2025. This research project investigates the cortical mechanisms by which psilocybin ameliorates chronic pain disorders, addressing a critical public health...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded the University of Pennsylvania $203,125 on March 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to support a two-year research project through February 29, 2028. This R21 exploratory research grant funds an investigation into the neural circuit mechanisms underlying the interaction between chronic pain and sleep disruption, specifically examining how dysregulation of the centrolateral thalamus to anterior cingulate cortex (CL-ACC) pathway contributes to sleep fragmentation and heightened pain sensitivity in chronic pain patients. The research deliverables include electrophysiological characterization of neural activity patterns, direct empirical evidence of chronic pain-induced disruption of the CL-ACC pathway, and innovative therapeutic insights on circuit modulation strategies. The interdisciplinary research team, led by Dr. Gregory Corder, Dr. Franz Weber, and Dr. Raquel Adaia Sandoval Ortega, will employ advanced neuroscience techniques including in vivo calcium imaging, closed-loop optogenetics, and deep-learning behavior tracking to assess how intervention on this neural circuit can simultaneously alleviate both pain and sleep disturbances. These research findings are intended to advance fundamental understanding of neurological mechanisms and inform potential therapeutic approaches for the approximately 90% of chronic pain patients who experience concurrent sleep disruption.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $203.1k | 2/12/26 |